Logo

American Heart Association

  22
  0


Final ID: MP562

AI-Measured Thoracic Ascending Aortic Calcification in CAC Scans Predicts Cardiovascular Events: An AI-CVD study in the FHS Offspring Cohort

Abstract Body (Do not enter title and authors here): Introduction/Background
The AI-CVD initiative aims to extract opportunistic screening information from coronary artery calcium scans to improve cardiovascular disease prediction. Thoracic aortic calcification (TAC) is a known marker of atherosclerotic burden but remains underutilized in routine coronary artery calcium scan interpretation. Automated quantification of TAC using artificial intelligence may enhance cardiovascular risk prediction, particularly when integrated with conventional risk scores.
Research Questions
We evaluated whether AI-derived TAC from coronary artery calcium scans independently predicts incident cardiovascular disease in the Framingham Heart Study Offspring cohort.
Goals
To assess whether automated TAC measured by the AutoTAC component of AI-CVD predicts future cardiovascular events independently of coronary artery calcium and traditional cardiovascular risk factors.
Methods
Baseline coronary artery calcium scans from 1,002 asymptomatic participants in the Framingham Heart Study Offspring cohort were analyzed using AI-enabled thoracic ascending aortic calcification quantification. TAC scores were categorized as 0, 1–99, 100–299, 300–999, and ≥1000. Cox proportional hazards models estimated hazard ratios for cardiovascular disease across TAC categories using unadjusted, age-adjusted, and fully adjusted models accounting for coronary artery calcium and established risk factors.
Results
296 CVD events accrued over 17 years follow-up. In fully adjusted models, compared to participants with zero TAC scores, participants with TAC scores of 100–299 had a hazard ratio of 2.05 (95% CI: 1.19–3.54), those with scores 300–999 had a hazard ratio of 2.29 (95% CI: 1.32–3.97), and those with scores ≥1000 had a hazard ratio of 2.85 (95% CI: 1.66–4.89). Lower categories (1–99) were not statistically significant after adjustment (HR 1.21, 95% CI: 0.73–2.03). The risk of cardiovascular disease increased progressively with higher TAC burden.
Conclusion(s)
In the FHS Offspring cohort, AI-measured TAC from coronary artery calcium scans was independently associated with future cardiovascular disease events over 17 years of follow-up. These findings support the utility of opportunistic AI-enabled aortic calcification assessment as an adjunct to traditional coronary artery calcium scoring in enhancing long-term risk stratification.
  • Naghavi, Morteza  ( HeartLung Technologies , Houston , Texas , United States )
  • Atlas, Kyle  ( HeartLung Technologies , Houston , Texas , United States )
  • Zhang, Chenyu  ( HeartLung Technologies , Houston , Texas , United States )
  • Reeves, Anthony  ( Cornell University , Ithaca , New York , United States )
  • Atlas, Thomas  ( Tustin Teleradiology , Tustin , California , United States )
  • Wasserthal, Jakob  ( University Basel , Basel , Switzerland )
  • Wong, Nathan  ( University of California, Irvine , Irvine , California , United States )
  • Benjamin, Emelia  ( Boston University School Medicine , Brookline , Massachusetts , United States )
  • Levy, Daniel  ( NHLBI-FRAMINGHAM HEART STUDY , Newton Highlands , Massachusetts , United States )
  • Author Disclosures:
    Morteza Naghavi: DO have relevant financial relationships ; Ownership Interest:HeartLung.AI:Active (exists now) | Kyle Atlas: No Answer | Chenyu Zhang: DO have relevant financial relationships ; Employee:HeartLung Corporation:Active (exists now) ; Individual Stocks/Stock Options:HeartLung Corporation:Active (exists now) | Anthony Reeves: DO have relevant financial relationships ; Individual Stocks/Stock Options:HeartLung Technologies:Active (exists now) | Thomas Atlas: No Answer | Jakob Wasserthal: DO have relevant financial relationships ; Consultant:HeartLungAi:Active (exists now) | Nathan Wong: DO have relevant financial relationships ; Research Funding (PI or named investigator):Amgen, Novartis, Ionis:Active (exists now) ; Consultant:Ionis:Past (completed) ; Speaker:Novartis:Past (completed) ; Consultant:Heart Lung, Amgen, Novartis:Active (exists now) ; Research Funding (PI or named investigator):Novo Nordisk, Regeneron:Past (completed) | Emelia Benjamin: DO NOT have relevant financial relationships | Daniel Levy: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Elsevier Publishing:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Artificial Intelligence in Imaging and Multimodal Biomarkers: Advancing Precision Diagnostics and Prognostics

Saturday, 11/08/2025 , 09:15AM - 10:25AM

Moderated Digital Poster Session

More abstracts on this topic:
Effects of Perivascular Adipose Tissue on Arterial Stiffness in an Adiposity-Driven Hypertension Model: A Longitudinal Study

Mcclintock Dillon, Bush Sydney, Sather Lisa, Tykocki Nathan, Watts Stephanie, Roccabianca Sara

3-Minute Heart Health App: A Feasibility Study

Abdulkarim Iya, Metzger Joseph, Stovitz Steven, Van't Hof Jeremy

More abstracts from these authors:
AI-driven Aortic Valve Calcification Measurement in Coronary Artery Calcium Scan Detects Aortic Stenosis Comparably to Human Experts: An AI-CVD Study within the Framingham Heart Study

Naghavi Morteza, Atlas Kyle, Zhang Chenyu, Reeves Anthony, Atlas Thomas, Wasserthal Jakob, Yankelevitz David, Henschke Claudia, Wong Nathan

AI-enabled Ascending Aorta and Pulmonary Trunk Volumetry in Coronary Artery Calcium Scans for Heart Failure Prediction: An AI-CVD Study within the Multi-Ethnic Study of Atherosclerosis (MESA)

Naghavi Morteza, Atlas Kyle, Zhang Chenyu, Reeves Anthony, Atlas Thomas, Wong Nathan, Wasserthal Jakob, Henschke Claudia, Yankelevitz David

You have to be authorized to contact abstract author. Please, Login
Not Available